Dr. Martens (LON:DOCS) Stock Price Down 9.6% – Should You Sell?

Shares of Dr. Martens plc (LON:DOCS) traded down 9.6% during mid-day trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares changed hands during trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Wall Street Analyst Weigh In

Separately, Peel Hunt restated a “buy” rating on shares of Dr. Martens in a research report on Thursday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of GBX 6,000.

Dr. Martens Price Performance

The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The stock’s 50-day moving average price is GBX 90.64 and its 200-day moving average price is GBX 80.35. The company has a market capitalization of £713.15 million, a price-to-earnings ratio of 147.60, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last posted its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities research analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insider Activity

In other Dr. Martens news, insider Ije Nwokori sold 298,675 shares of the company’s stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total transaction of £268,807.50. Also, insider Giles Wilson sold 30,000 shares of the firm’s stock in a transaction dated Monday, September 1st. The shares were sold at an average price of GBX 91, for a total transaction of £27,300. Over the last three months, insiders have acquired 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. Insiders own 2.80% of the company’s stock.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.